Thibault Boutherin (Morgan Stanley) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Thibault Boutherin's stock ratings?

About 62% of Thibault's ratings were profitable over a one-year hold, with an average return of +13.7% per rating, measured by 13Foresight from historical prices.

Q: How is Thibault ranked?

Thibault Boutherin is ranked #1192 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Thibault Boutherin

Thibault Boutherin

Morgan Stanley

Wall Street Analyst

★★★☆☆

#1192

on 13Foresight · ranked by our own returns

62%

Success Rate

+13.4%

Average Return

5 of 8 calls profitable · -4.3% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 62% of Thibault Boutherin's ratings turned a profit when each position was held for 1 year — averaging +13.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

19 Buy 17 Hold 3 Sell

Thibault's Stock Coverage 26 ratings · 2026-07-14

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
CH:NOVN Novartis AG	Jun 25, 2026	BUY	Buy -13.7% avg upside 31 analysts	$135.00 8.62% Upside	·
GB:0QIU Novo Nordisk	May 07, 2026	HOLD	Buy +27.2% avg upside 29 analysts	$250.00 22.24% Downside	·
CH:GALD Galderma Group AG	Apr 27, 2026	HOLD	Strong Buy +8.4% avg upside 10 analysts	$160.00 5.73% Downside	·
NVS Novartis	Mar 26, 2026	BUY	Buy -11.7% avg upside 24 analysts	$170.00 10.30% Upside	+0.4%
DE:BAYN Bayer	Mar 11, 2026	BUY	Strong Buy +4.4% avg upside 28 analysts	$53.00 6.61% Upside	·
ES:GRF Grifols	Mar 10, 2026	HOLD	Buy +65.8% avg upside 12 analysts	$11.00 23.26% Upside	·
NVO Novo Nordisk	Mar 03, 2026	HOLD	Buy +135.2% avg upside 26 analysts	$40.00 19.10% Downside	+39.9%
INDV Indivior	Dec 03, 2025	BUY	Strong Buy -11.1% avg upside 10 analysts	$36.00 11.19% Downside	+18.2%
CH:SDZ Sandoz Group Ltd	Dec 03, 2025	HOLD	Buy -0.4% avg upside 11 analysts	$50.00 24.94% Downside	·
ALVO Alvotech	Dec 03, 2025	BUY	Strong Buy +138.8% avg upside 6 analysts	$10.00 204.90% Upside	-28.9%
CH:LONN Lonza Group Ltd	Dec 03, 2025	BUY	Strong Buy +9.9% avg upside 20 analysts	$650.00 11.43% Upside	·
DE:MRK Merck KGaA	Dec 03, 2025	HOLD	Buy -2.3% avg upside 33 analysts	$135.00 2.83% Downside	·
FR:DIM Sartorius Stedim Biotech	Apr 22, 2025	BUY	Strong Buy +33.6% avg upside 11 analysts	$250.00 35.43% Upside	·
DE:SRT3 Sartorius	Apr 22, 2025	BUY	Buy +12.0% avg upside 18 analysts	$300.00 22.69% Upside	·
GB:0QW0 arGEN X	Mar 05, 2025	BUY	Strong Buy -23.6% avg upside 24 analysts	$715.00 10.12% Downside	·
GB:HIK Hikma Pharmaceuticals	Feb 12, 2025	HOLD	Strong Buy +47.6% avg upside 8 analysts	$2400.00 53.64% Upside	·
DE:EVT Evotec	Jul 29, 2024	HOLD	Buy +303.6% avg upside 8 analysts	$12.00 143.95% Upside	·
EVO Evotec AG	Jul 29, 2024	HOLD	Strong Buy +292.9% avg upside 9 analysts	$13.68 390.99% Upside	-10.9%
GB:BEZ Beazley	Jul 15, 2024	BUY	Strong Buy +155.4% avg upside 14 analysts	$912.00 29.03% Downside	·
FR:IPN Ipsen	May 15, 2024	HOLD	Hold -23.5% avg upside 17 analysts	$120.00 26.17% Downside	·
SDZNY Sandoz Group Ltd Sponsored ADR	May 08, 2024	HOLD	Buy -48.3% avg upside 2 analysts	$39.50 52.87% Downside	+32.1%
CH:IDIA Idorsia Ltd	Apr 03, 2024	SELL	Hold -25.6% avg upside 8 analysts	$1.00 83.33% Downside	·
GB:0NZT UCB SA	Mar 25, 2024	HOLD	Strong Buy -7.8% avg upside 19 analysts	$105.00 57.36% Downside	·
GRFS Grifols SA	Dec 29, 2023	HOLD	Buy +247.4% avg upside 12 analysts	$15.96 119.53% Upside	-33.8%
ES:ALM Almirall	Nov 13, 2023	HOLD	Buy +21.2% avg upside 5 analysts	$11.00 0.83% Upside	·
TEVA Teva Pharmaceutical	Oct 04, 2023	HOLD	Buy -9.2% avg upside 39 analysts	$10.00 69.57% Downside	+90.3%

🔒 21 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Thibault Boutherin — Frequently Asked Questions

How accurate are Thibault Boutherin's stock ratings?

Based on the calls 13Foresight could measure, about 62% of Thibault's ratings were profitable over a one-year hold, with an average return of +13.7% per rating, or -4.1% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Thibault ranked on 13Foresight?

Thibault Boutherin is currently ranked #1192 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Thibault cover?

Thibault most recently has ratings on CH:NOVN, GB:0QIU, CH:GALD, NVS, DE:BAYN, ES:GRF, NVO, INDV, CH:SDZ, ALVO, CH:LONN, DE:MRK and 14 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!